| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $220.2M | +471.2% |
| R&D Expense | $65.5M | -34.0% |
| SG&A Expense | $98.0M | +14.0% |
| Operating Income | $9.8M | +106.2% |
| Pre-tax Income | $11.0M | +107.0% |
| Income Tax | -$172.3M | — |
| Net Income | $183.4M | +216.1% |
| EPS (Basic) | $2.64 | +214.8% |
| EPS (Diluted) | $2.60 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.7M | +0.2% |
| Short-term Investments | $67.9M | +13.7% |
| Accounts Receivable | $12.7M | +217.7% |
| Inventory | $21.6M | +487.7% |
| Current Assets | $243.1M | +23.7% |
| Total Assets | $459.7M | +97.5% |
| Current Liabilities | $47.1M | +5.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.8M | +104.6% |
| Capital Expenditures | $105K | -74.7% |
| Investing Cash Flow | -$8.1M | -106.3% |
| Financing Cash Flow | $2.5M | -57.2% |
| Free Cash Flow | $5.7M | +104.5% |
| +213.0% |
| Total Liabilities |
| $63.5M |
| +33.0% |
| Stockholders' Equity | $396.1M | +114.1% |